Recent YSCC Discoveries

Scientists created a cellular atlas of the lungs to pinpoint cells especially vulnerable to aging. They could be targets for preventing acute and chronic lung diseases.

The gift will support groundbreaking studies, the development of new therapies, and comprehensive clinical care initiatives focused on TKT deficiency.

Yale scientists have engineered natural killer cells that eliminate solid tumors in mouse models. The study may lead to a simpler, “off the shelf” immunotherapy for hard-to-treat cancers.

Postdoctoral Associate Jonathan Weerakkody, PhD, won the Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award for "miRNA Signatures in Astrocyte-Enriched Small Extracellular Vesicles as Biomarker for Multiple Sclerosis Progression."

On February 6, 2026, YCC CRTEC welcomed students from Hill Regional Career High School to our Cancer Research Discovery Program (CRDP), a day designed to introduce them to careers in cancer research and medicine.

“In many ways, my immigrant journey has strengthened my curiosity, sharpened my focus, and taught me to value collaboration and diverse perspectives,” says Berna Sozen, a developmental biologist at Yale School of Medicine.

The Tommy Fund for Childhood Cancer is a non-profit organization that supports pediatric oncology and hematology patients at Smilow Cancer Hospital as well as their families, the medical and support staff.

Berna Sozen, PhD, was awarded the prize in recognition of her research, which has enhanced understanding of embryonic development.

People diagnosed with chronic obstructive pulmonary disease often experience markedly different symptoms, disease trajectories, and responses to treatment. To better understand this variability, a new study from researchers at Yale School of Medicine used single-cell sequencing technology alongside complementary spatial transcriptomic and proteomic analyses to examine lung tissue from people with COPD in unprecedented detail.